Nanjing Vishee Medical Technology Co., Ltd. was founded in 2001, mainly engaged in the R&D, production and sales of rehabilitation medical equipment and products, dedicated to the Pelvic Floor Rehabilitation, Postpartum Rehabilitation, Neurological Rehabilitation, Psychiatric Rehabilitation and other areas to provide safe and effective rehabilitation products and solutions for medical and professional institutions. At present, the main products of the company are electrical stimulation, magnetic stimulation, Electrophysiological equipment, consumables and accessories,etc.
The company's products have been widely used in more than 6000 medical and professional institutions in China. From 2017 to 2019, the average annual compound growth rate of operating revenue and net profit were 48.55% and 56.86% respectively, ranking the top among the rehabilitation equipment enterprises in China that have publicly disclosed their operating data in terms of revenue scale.
The Company is conducting R&D of new products such as next-generation magnetic stimulator and rehabilitation robot and will continue to align itself with the technological development direction of international leading enterprises in each segment, continuously achieve technological breakthroughs, speed up the transformation of the Company's advanced technologies, further enhance the market competitiveness of the Company's products and strive to develop into a leading rehabilitation medical equipment company in the future.
|Earnings Per Share(Yuan)||1.95||1.24||0.80|
|R&D expenditure as a % of operating revenue||8.59%||8.92%||9.03%|
|Total Owners' Equity||254.86||196.16||153.42|
|Net Cash Flows-Operating||141.47||85.84||52.35|
|Net Cash Flows-Investing||-16.90||-37.55||-12.69|
|Net Cash Flows-Financing||-42.45||-21.49||2.26|
|Name||No. of Shares Held (mn)||% of Shares Held|
|Nanjing Zhida Investment Management Consulting Center Ltd., Part||5.67||8.29%|
|Shenzhen Yanghe Biomedicine Industry Investment Co.,Ltd||3.51||5.13%|
|Nanjing Zhimingda Enterprise Management Consulting Center Ltd., Part||1.26||1.84%|
|Changjiang Securities Innovation Investment Co., Ltd||0.68||1.00%|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.